KDR Antibody - N-terminal region

Produktübersicht

• Artikelname: KDR Antibody - N-terminal region
• Artikelnummer: ASB-AVARP20010_P050
• Hersteller Artikelnummer: AVARP20010_P050
• Alternativnummer: ASB-AVARP20010_P050-25UL,ASB-AVARP20010_P050-100UL
• Hersteller: Aviva
• Wirt: Rabbit
• Kategorie: Proteine/Peptide
• Applikation: IHC, WB
• Spezies Reaktivität: Bovine, Canine, Equine, Human, Porcine
• Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human KDR
• Alternative Synonym: FLK1, CD309, VEGFR, VEGFR2

Produktbeschreibung

KDR is the receptor for VEGF or VEGFC. It has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposis sarcoma lesions.

Produkteigenschaften

• Klonalität: Polyclonal
• Konzentration: 0.5 mg/ml
• Molekulargewicht: 151kDa
• NCBI: 3791
• UniProt: P35968
• Formulierung: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.

Bilder

KDR in endothelial cells in blood vessels in placenta was detected using HRP/AEC red color stain.recommended for IHC on human tissue.5-10 ug/mL

Researcher: Department of Pathology, Hospital de Carabineros de Chile, Santiago, Chile
Application: IHC
Species+tissue/cell type: Control-Human Placenta, Sample-Human colorectal cancer
Primary antibody dilution: 1:100
Secondary antibody: Biotinylated pig anti-rabbit+streptavidin-HRP

WB Suggested Anti-KDR Antibody Titration: 0.2-1 ug/ml
ELISA Titer: 1:62500
Positive Control: Human Lung

Host: Rabbit
Target Name: KDR
Sample Tissue: Human A549 Whole Cell
Antibody Dilution: 1ug/ml

KDR antibody - N-terminal region (AVARP20010_P050) in Human Lung using Western Blot